Joong‐Won Park
Impact in
- Hepatology top 0.05%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Cancer Research top 1%
Papers in
- Hepatology 128
- Hepatocellular Carcinoma Treatment and Prognosis 114
- Liver physiology and pathology 17
- Hepatitis C virus research 15
- Epidemiology 57
- Liver Disease Diagnosis and Treatment 41
- Hepatitis B Virus Studies 28
- Co-authors
- Gregory J. GoresTushar PatelMasatoshi KudoJosep M. LlovetPeter R. GalleTimothy M. PawlikShahid A. KhanJohn Bridgewater
- Journals
- Journal of Clinical Oncology (18 papers)Journal of Hepatology (12 papers)Journal of Gastroenterology and Hepatology (9 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)Journal of Cancer Research and Clinical Oncology (7 papers)
- Partner nations
- South KoreaUnited StatesTaiwan
In The Last Decade
Joong‐Won Park
159 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Hepatology 5.4k
- Cancer Research 1.5k
- Pathology and Forensic Medicine 1.6k
- Oncology 2.3k
- Epidemiology 2.6k
Countries citing papers authored by Joong‐Won Park
This map shows the geographic impact of Joong‐Won Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joong‐Won Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joong‐Won Park more than expected).
Fields of papers citing papers by Joong‐Won Park
This network shows the impact of papers produced by Joong‐Won Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joong‐Won Park. The network helps show where Joong‐Won Park may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joong‐Won Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW. Hit paper breakdown → | 2024 | 75 |
| 2 | 2024 | 31 | |
| 3 | 2023 | 15 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 36 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 66 | |
| 10 | 2020 | 17 | |
| 11 | 2020 | 29 | |
| 12 | 2015 | 1 | |
| 13 | 2014 | 86 | |
| 14 | 2014 | 65 | |
| 15 | 2012 | 158 | |
| 16 | 2011 | 110 | |
| 17 | 2010 | 30 | |
| 18 | 2008 | 9 | |
| 19 | 2008 | 29 | |
| 20 | A case of simple type Caroli's disease confined to one segment of the liver. | 2005 | 1 |
About Joong‐Won Park
Joong‐Won Park is a scholar working on Hepatology, Epidemiology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 164 papers that have together received 8.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (114 papers), Liver Disease Diagnosis and Treatment (41 papers), Hepatitis B Virus Studies (28 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers), Cancer Mechanisms and Therapy (21 papers), Liver physiology and pathology (17 papers), Renal cell carcinoma treatment (15 papers) and Hepatitis C virus research (15 papers). The work is most often cited by research in Hepatology (5.4k citations), Cancer Research (1.5k citations), Pathology and Forensic Medicine (1.6k citations), Oncology (2.3k citations) and Epidemiology (2.6k citations). Joong‐Won Park has collaborated with scholars based in South Korea, United States and Taiwan. Frequent co-authors include Gregory J. Gores, Tushar Patel, Masatoshi Kudo, Josep M. Llovet, Peter R. Galle, Timothy M. Pawlik, Shahid A. Khan, John Bridgewater, Bo Hyun Kim and Tae Hyun Kim. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hepatology, Journal of Gastroenterology and Hepatology, International Journal of Radiation Oncology*Biology*Physics and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.